Mohmmed Muqtader Ahmed

Pharmacology, Toxicology and Pharmaceutical Science

1. Nanoparticle 100%
2. Bioavailability 85%
3. Drug Release 81%
4. Chitosan 71%
5. Pharmacokinetic 71%
6. Sustained Release 63%
7. Breast Cancer 57%
8. Cytotoxicity 54%
9. Solid Lipid Nanoparticle 50%
10. Differential Scanning Calorimetry 42%
11. Cyclodextrin 42%
12. Zeta Potential 41%
13. Scanning Electron Microscopy 37%
14. Ethyl Cellulose 36%
15. Wound Healing 35%
16. Drug Delivery System 34%
17. Anti-Inflammatory Drug 33%
18. Apigenin 32%
19. Tablet 32%
20. Antioxidant Capacity 30%
21. Non Small Cell Lung Cancer 28%
22. Antioxidant 24%
23. Amorphous Solid Dispersion 24%
24. Delafloxacin 24%
25. Glycyrrhizin 24%
26. Baricitinib 24%
27. Apremilast 24%
28. Silver Nanoparticle 24%
29. Diabetes Mellitus 23%
30. Nanocarrier 22%
31. Phytochemical 21%
32. Rat Model 21%
33. Malignant Neoplasm 20%
34. Polyvinyl Alcohol 19%
35. Antimicrobial Agent 19%
36. Acetic Acid Ethyl Ester 19%
37. Erectile Dysfunction 18%
38. Tumor Necrosis Factor 17%
39. Polyglactin 17%
40. Antiinfective Agent 16%
41. Lung Cancer 16%
42. Osimertinib 16%
43. Diosmin 16%
44. Olaparib 16%
45. Agents Acting on the Eye 16%
46. Tadalafil 16%
47. Malonaldehyde 15%
48. Poloxamer 14%
49. Flavonoid 14%
50. Wound 14%